CIPF brings together top experts in the field of Medicinal Chemistry
Interaction and cooperation between academic research and pharmaceutical industry was promoted.
The Príncipe Felipe Research Centre hosted the XVI National Congress of the Spanish Society of Medicinal Chemistry. This initiative intended to promote this type of multidisciplinary research work among the Spanish scientific community, facilitate interaction between the academic world and pharmaceutical industry, and develop translational research.
This congress was organized by SEQT, the Spanish Society of Medicinal Chemistry, a non-profit, multidisciplinary organization which intends to embrace all those professionals, firms and organizations whose activity is related with Spanish pharmaceutical R&D. SEQT´s purpose is to help therapeutic chemicals to develop by organizing scientific meetings to not only encourage professional contacts at national and international levels, but to contribute to training professionals in this particular field. Given its scientific relevance, this event has been included in the activities organized during the International Year of Chemistry 2011 (IYC2011).
The event was supported by pharmaceutical companies, FIVEC, San Pablo CEU University and Spanish Ministry of Science and Innovation. The event was qualified as an special interest activity by the Scientific Committee of the INTERBIO project, in the category Interbio Label.
Dr. Antonio Pineda-Lucena, Principal Investigator of CIPF´s Structural Biochemistry Laboratory, was the organizer of this congress, which have welcomed top experts in the therapeutic chemicals field. Likewise, the Organizing Committee of this congress is formed by researchers belonging to CIPF, the Spanish Higher Council for Scientific Research (CSIC), Valencia University and the “La Fe” Healthcare Research Institute.
More than 150 people attended this forum for specialists where professional academic and industrial researchers specialized in different branches like chemistry, pharmaceuticals and biology met and debated the latest advances in the discovery of drugs, and tried to offer answers to some of the challenges that this type of research faces today.
This event was an opportunity to participate in a forum where top experts shared their studies and their opinion about the future of drug discovery, in an interdisciplinary atmosphere between biology and chemistry.
The programme included subjects such as designing new therapeutic agents (small molecules, antibodies, biological drugs, etc.), new biochemical strategies (incorporating new technologies to discover drugs, e.g., the “omics” techniques), or the discovery of new approaches to study highly complex therapeutic targets (protein-protein interactions, the study into receptors, etc).
Experts had the possibility to know the latest findings in the design of new therapeutic agents, and the opportunity to interact and stablish new contacts and collaboration strategies. Moreover, the congress was an open forum to form young scientists interested in medicinal chemistry.
This congress paid attention to the complementary visions which academic researchers and pharmaceutical industry are able to offer by means of a scientific programme that provides a multidisciplinary perspective of the research done in the medicinal chemistry field.
In this way, the congress was considered an opportunity to promote scientific discussion, debate and relationships among researchers from the various academic and industrial fields in order to combine efforts to achieve competitive results.